JPY 3715.0
(-2.37%)
Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
---|---|---|---|---|---|---|
Operating Cash Flow | 4.16 Billion | 1.11 Billion | 1.7 Billion | 10.77 Billion | -2.08 Billion | 5.8 Billion |
Net Income | 4.8 Billion | 6.61 Billion | 6.4 Billion | 4.6 Billion | 5.09 Billion | 3.75 Billion |
Depreciation & Amortization | 209 Million | 191 Million | 161 Million | 168 Million | 172 Million | 174 Million |
Deferred income taxes | - | - | - | - | - | - |
Stock-based compensation | - | - | - | - | - | - |
Change in working capital | -266 Million | -4.34 Billion | -3.57 Billion | 7.02 Billion | -3.08 Billion | 313 Million |
Other non-cash items | 52 Million | -1.34 Billion | -1.29 Billion | -1.02 Billion | -4.25 Billion | 1.55 Billion |
Investing Cash Flow | 244 Million | -2.55 Billion | -269 Million | 172 Million | 12.35 Billion | 1.6 Billion |
Investments in PPE | -306 Million | -365 Million | -108 Million | -63 Million | -129 Million | -192 Million |
Acquisitions | - | -160 Million | -2 Million | -27 Million | -79 Million | -148 Million |
Investment purchases | -4.41 Billion | -5.41 Billion | -1.03 Billion | -717 Million | -1.09 Billion | -1.02 Billion |
Sales/Maturities of investments | 4.94 Billion | 3.2 Billion | 832 Million | 909 Million | 13.5 Billion | 2.74 Billion |
Other Investing Activities | 21 Million | 186 Million | 39 Million | 70 Million | 150 Million | 224 Million |
Financing Cash Flow | -3.38 Billion | -3.59 Billion | -2.86 Billion | -1.94 Billion | -2.51 Billion | -2.43 Billion |
Debt repayment | -6 Million | -8 Million | -4 Million | -14 Million | -7 Million | -4 Million |
Dividends payments | -1.97 Billion | -1.96 Billion | -1.92 Billion | -1.92 Billion | -1.94 Billion | -1.72 Billion |
Common Stock Repurchased | -1.68 Billion | -1.62 Billion | -941 Million | - | -567 Million | -703 Million |
Common Stock Issuance | 284 Million | 8 Million | 4 Million | - | 7 Million | 4 Million |
Other Financing Activities | -2 Million | -11 Million | -5 Million | -3 Million | -10 Million | -6 Million |
Accounts receivables | 1.84 Billion | -9.33 Billion | -3.43 Billion | 8.06 Billion | -5.09 Billion | 2.75 Billion |
Accounts payables | -1.65 Billion | 5.13 Billion | -677 Million | -3.55 Billion | 875 Million | -2.15 Billion |
Inventory | -406 Million | -245 Million | -62 Million | 3.55 Billion | -140 Million | 132 Million |
Other working capital | -55 Million | 104 Million | 608 Million | -1.03 Billion | 1.27 Billion | -420 Million |
Cash at beginning of period | 20.93 Billion | 32.96 Billion | 34.39 Billion | 25.39 Billion | 17.64 Billion | 12.66 Billion |
Cash at end of period | 20.95 Billion | 27.92 Billion | 32.96 Billion | 34.39 Billion | 25.39 Billion | 17.64 Billion |
Capital Expenditure | -306 Million | -365 Million | -108 Million | -63 Million | -129 Million | -192 Million |
Effect of forex changes on cash | - | - | -1 Million | - | - | 1 Million |
Net cash flow / Change in cash | 26 Million | -5.03 Billion | -1.43 Billion | 9 Billion | 7.75 Billion | 4.97 Billion |
Free Cash Flow | 3.86 Billion | 751 Million | 1.59 Billion | 10.7 Billion | -2.21 Billion | 5.6 Billion |
Breakdown | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 | 2023 Q1 |
---|---|---|---|---|---|---|
Operating Cash Flow | - | - | - | - | - | - |
Net Income | 828 Million | 2.92 Billion | 4.8 Billion | 918 Million | 416 Million | 540 Million |
Depreciation & Amortization | - | - | 209 Million | 49 Million | 50 Million | 46 Million |
Deferred income taxes | - | - | - | - | - | - |
Stock-based compensation | - | - | - | - | - | - |
Change in working capital | - | - | -266 Million | - | - | - |
Other non-cash items | -828 Million | -2.92 Billion | 52 Million | -918 Million | -416 Million | -540 Million |
Investing Cash Flow | - | - | 244 Million | - | - | - |
Investments in PPE | - | - | -306 Million | - | - | - |
Acquisitions | - | - | - | - | - | - |
Investment purchases | - | - | -4.41 Billion | - | - | - |
Sales/Maturities of investments | - | - | 4.94 Billion | - | - | - |
Other Investing Activities | - | - | 21 Million | - | - | - |
Financing Cash Flow | - | - | -3.38 Billion | - | - | - |
Debt repayment | - | - | -6 Million | - | - | - |
Dividends payments | - | - | -1.97 Billion | - | - | - |
Common Stock Repurchased | - | - | -1.68 Billion | - | - | - |
Common Stock Issuance | - | - | 284 Million | - | - | - |
Other Financing Activities | - | - | -2 Million | - | - | - |
Accounts receivables | - | - | 1.84 Billion | - | - | - |
Accounts payables | - | - | -1.65 Billion | - | - | - |
Inventory | - | - | -406 Million | - | - | - |
Other working capital | - | - | -55 Million | - | - | - |
Cash at beginning of period | - | - | 20.93 Billion | 21.56 Billion | 27.81 Billion | 20.93 Billion |
Cash at end of period | - | - | 20.95 Billion | 22.07 Billion | 21.56 Billion | 27.81 Billion |
Capital Expenditure | - | - | -306 Million | - | - | - |
Effect of forex changes on cash | - | - | - | - | - | - |
Net cash flow / Change in cash | - | - | 26 Million | 510 Million | -6.24 Billion | 6.88 Billion |
Free Cash Flow | - | - | 3.86 Billion | 98 Million | 100 Million | 92 Million |
BRSR6
AT
CANTABIL
STARHEALTH
VRNS
STARCEMENT